Skip to main content
FinSpry Logo
FinSpry
IMCR logo
IMCR
(NASDAQ)
Immunocore Holdings plc
$30.83-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Immunocore Holdings (IMCR) Stock Price & Financial Analysis

Immunocore Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$29.81 - $31.25
52-Week High$40.72
52-Week Low$23.15
Open$29.81
Volume477.44K
Average Volume (3M)477.44K
Market Cap1.55B
Shares Outstanding50.35M
Price to Sales (P/S)4.09
Price to Book (P/B)4.00
EV/EBITDA-1293.73
Revenue (TTM)372.97M
Net Income (TTM)-27.73M
Free Cash Flow (TTM)-15.05M
EPS (TTM)$-0.55
Profit Margin-7.44%
Operating Margin-10.79%
Return on Equity (ROE)-7.28%
Debt to Equity0.11
50-Day MA$32.14
200-Day MA$33.78
52-Week Change5.87%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Immunocore Holdings

What is the current stock price for IMCR?

As of the latest trading session, IMCR stock trades at $30.83. The 52-week range is $23.15–$40.72, with a day range of $29.81–$31.25.

What is the P/E ratio for IMCR?

The P/E ratio (Price-to-Earnings) for IMCR is shown in the Key Statistics section. This valuation metric helps compare Immunocore Holdings plc to industry peers.

Does IMCR pay dividends?

Immunocore Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IMCR?

Based on 4 analysts, the consensus for IMCR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IMCR?

Immunocore Holdings's market capitalization is $1.55B, classifying it as a small-cap company. Immunocore Holdings operates in the Healthcare sector within the Biotechnology industry.